Biomedical/Biotechnology

$33,800 lab monkeys show China’s quest to rival US biotech

To get regulatory clearance for biologics trials, companies often must provide monkey data to demonstrate likely human safety.

Singapore-based lab to produce clinical trial doses for potential new Ebola vaccine

Hilleman Laboratories has secured up to US$8.5 million in funding from global health body CEPI to develop and produce the Ebola vaccine candidate.

GP resource for pre-university students: How will biotechnology change human life?

The revolutionary potential of biotechnology has also been accompanied by question marks over the ethical implications of its application.

Scientists made a cell with most of the hallmarks of life. Here’s what to know

PHOTO: ADAMALA LAB

Biotechnology could revolutionise human life. Should it be allowed to?

As science pushes the frontiers of what is known about cancer and other diseases – allowing for new medicines to be developed – digital technology too, is pushing boundaries

Branded Content

From start-up to HK IPO: How global standards drove S’pore biomedical firm’s expansion

Mirxes' senior vice president of operations, Jeremiah Decosta with GASTROClear test kits in temperature-controlled storage

China lures foreign patients with cutting-edge, cheap medical care

A fellow New Zealand patient who had received the treatment in China introduced Stuart Lye to a hospital in Shanghai.

New life sciences hub Geneo to link companies with talent, foster collaboration

Geneo, the new life sciences and research hub in Science Park, aims to foster a vibrant ecosystem for firms and start-ups in the sector.

Inside an African lab that helped crack the hantavirus outbreak

A drone view of the cruise ship MV Hondius, carrying passengers suspected of having cases of hantavirus on board, leaves Praia, Cape Verde, on May 6.

Life After... biotech winter: CellResearch Corp goes from zero to $25m revenue in just 4 years

Founding Director and CEO of CellResearch Corporation Gavin Tan said the biotech company will return to its core passion and and list on NASDAQ after 24 years.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.